Evolocumab AI/pen
Sponsors
Amgen
Conditions
Mixed DyslipidemiaPrimary Hypercholesterolemia
Phase 3
Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen
CompletedNCT01849497
Start: 2013-04-18Updated: 2018-11-29
Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen
CompletedNCT01879319
Start: 2013-07-11Updated: 2022-11-30